M OST STORIES about gene-edited children begin with He Jiankui, a rogue Chinese scientist who, in 2018, announced that he had ...
The first gene-editing therapies for HIV/Aids are entering trials but the virus is proving once again that it is a master at ...
Protests will be held in Whangārei and Kerikeri on Saturday as part of nationwide action.
No doubt the New Zealand Gene Technology Bill, currently awaiting its Second Reading, which will liberalise decisions about gene technology experiments and place them in the hands of a single ...
Jeff Bartel is chairman and managing director of Hamptons Group, a private investment and strategic advisory firm headquartered in Miami. Gene editing technology, a major biotechnology advance, is ...
Using CRISPR gene editing technology, researchers from Jiangnan University in China took a fungus that is already used as a ...
The inaugural Genetic Agency Technology Conference (GATC) on November 11th, 2025 will convene technical thought leaders, gene therapy developers, patients, their families, and patient advocates across ...
Zacks Investment Research on MSN
BEAM vs. NTLA: Which Gene Editing Stock Holds More Potential?
Beam Therapeutics BEAM and Intellia Therapeutics NTLA are clinical-stage companies developing investigational gene therapies.
The new GE technology — for which the Indian Council of Agricultural Research (ICAR) has recently been granted a patent — ...
Malaria remains one of the world’s deadliest diseases. Each year malaria infections result in hundreds of thousands of deaths, with the majority of fatalities occurring in children under five. The ...
Higher yields, greater resilience to climatic changes or diseases—the demands on crop plants are constantly growing. To ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback